24 maggio 2021 07:05
Fonte: Adnkronos
#salute-e-benessere
SEOUL, South Korea, May 21, 2021 /PRNewswire/ -- On the 20th, the Medical robot specialist company CUREXO Corp. (060280) announced their independently developed spinal surgery robot 'CUVIS-spine' has acquired FDA (US) licensing.
This FDA (US) license, followed by Korea (2019) and Europe CE (2020) certificate is the 3rd license that they have acquired and now their product can be supplied to all countries.
Currently, 2 'CUVIS-spine's are being used in Severance Hospital (Korea) and 1 has been exported to an Australian medical facility company. CUREXO also plans to expand their focus on global markets including the US and Europe.
Spinal surgery robot 'CUVIS-spine' is a next-gen spinal surgery robot that guides the insertion of a pedicle screw according to the surgery plan. It uses a high precision robot arm, wireless one-step, navigation based on a real-time GPS sensor to provide precise, safe and faster surgery compared to traditional manual surgery. Also, it minimizes the filming and reduces the radiation exposure of both patients and medical staff.